Optimizing Rehabilitation for Phantom Limb Pain Using Mirror Therapy and Transcranial Direct Current Stimulation (tDCS)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02487966 |
Recruitment Status :
Active, not recruiting
First Posted : July 2, 2015
Results First Posted : June 21, 2021
Last Update Posted : August 15, 2022
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Phantom Limb Pain Amputation, Traumatic | Device: transcranial Direct Current Stimulation (tDCS): active (Soterix ©) Behavioral: Mirror Therapy: active Device: transcranial Direct Current Stimulation (tDCS): sham (Soterix ©) Behavioral: Mirror Therapy: Sham | Not Applicable |
Phantom limb pain (PLP) belongs to a group of neuropathic pain syndromes that is characterized by pain in the amputated limb. Rehabilitation for chronic pain involves a structured treatment plan targeting all dimensions of the pain experience, and should include a comprehensive interdisciplinary approach that allows patients to receive the most benefit according to their needs. As in other chronic pain syndromes, chronic Phantom limb pain (PLP) is often difficult to treat; showing to be resistant to classical pharmacological and surgical treatment approaches.
In this context, we hypothesize that novel treatments of PLP need to target specific neural networks associated with this maladaptive plasticity. Transcranial direct current stimulation (tDCS,Soterix ©) is a powerful and non-invasive technique of brain stimulation that is known to significantly modulate plasticity and alleviate chronic pain in various syndromes. device for this trial. This study usiGiven tDCS underlying neural mechanisms, it is critical to use a multimodal approach to treatment - using both tDCS and behavioral therapy simultaneously. In this case, an ideal therapy is mirror therapy (MT).
Recently, we showed that anodal tDCS can induce a selective short-lasting relief from PLP, and repeated applications of anodal tDCS induces long-lasting analgesic effects. These preliminary results show that tDCS may be a promising rehabilitative tool for the management of chronic PLP. This neurorehabilitation technique is commonly used in PLP, and is designed to modulate cortical mechanisms of pain by performing movements using the unaffected limb in front of a mirror. We propose to carry out a mechanistic, factorial, randomized controlled trial to evaluate a novel rehabilitation approach combining tDCS and MT in PLP patients. We aim to compare the brain changes before and after treatment in order to study the mechanisms underlying PLP.
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 132 participants |
Allocation: | Randomized |
Intervention Model: | Factorial Assignment |
Masking: | Triple (Participant, Investigator, Outcomes Assessor) |
Primary Purpose: | Treatment |
Official Title: | Optimizing Rehabilitation for Phantom Limb Pain Using Mirror Therapy and Transcranial Direct Current Stimulation (tDCS) |
Study Start Date : | July 2015 |
Actual Primary Completion Date : | March 27, 2020 |
Estimated Study Completion Date : | December 21, 2023 |

Arm | Intervention/treatment |
---|---|
Experimental: Active tDCS and Active Mirror Therapy
Subjects will receive 20 minutes of active tDCS, while receiving 15 minutes of active Mirror Therapy.
|
Device: transcranial Direct Current Stimulation (tDCS): active (Soterix ©)
Subjects will undergo tDCS stimulation. For both active and sham stimulation, we will use electrodes of 35cm^2, at an intensity of 2mA on the primary motor cortex contralateral to the amputated leg. For active tDCS, the subject will undergo stimulation for 20 minutes. Behavioral: Mirror Therapy: active Subjects will be asked to perform movements (15 minutes daily) using the unaffected limb while watching its mirrored reflection superimposed over the affected limb. During Mirror Therapy, subjects will be asked to consciously relate the movement observed in the mirror to their phantom limb and to keep their attention focused on the task. Instructions will be explained verbally, demonstrated by a therapist, and performed by the subject in front of the therapist. |
Experimental: Active tDCS and sham Mirror Therapy
Subjects will receive 20 minutes of active tDCS, while receiving 15 minutes of sham Mirror Therapy.
|
Device: transcranial Direct Current Stimulation (tDCS): active (Soterix ©)
Subjects will undergo tDCS stimulation. For both active and sham stimulation, we will use electrodes of 35cm^2, at an intensity of 2mA on the primary motor cortex contralateral to the amputated leg. For active tDCS, the subject will undergo stimulation for 20 minutes. Behavioral: Mirror Therapy: Sham Subjects will be asked to perform movements (15 minutes daily) using the unaffected limb while watching its mirrored reflection superimposed over the affected limb, only the mirror will be covered. During Mirror Therapy, subjects will be asked to consciously relate the movement observed in the mirror to their phantom limb and to keep their attention focused on the task. Instructions will be explained verbally, demonstrated by a therapist, and performed by the subject in front of the therapist. We will use the same all of these techniques as active Mirror Therapy only the mirror will be covered during all activities. |
Experimental: Sham tDCS and active Mirror Therapy
Subjects will receive 20 minutes of sham tDCS, while receiving 15 minutes of active Mirror Therapy.
|
Behavioral: Mirror Therapy: active
Subjects will be asked to perform movements (15 minutes daily) using the unaffected limb while watching its mirrored reflection superimposed over the affected limb. During Mirror Therapy, subjects will be asked to consciously relate the movement observed in the mirror to their phantom limb and to keep their attention focused on the task. Instructions will be explained verbally, demonstrated by a therapist, and performed by the subject in front of the therapist. Device: transcranial Direct Current Stimulation (tDCS): sham (Soterix ©) Subjects will undergo tDCS stimulation. For both active and sham stimulation, we will use electrodes of 35cm^2, at an intensity of 2mA on the primary motor cortex contralateral to the amputated leg. The subject will undergo stimulation for 20 minutes. This is the same parameters as the active one, except the current will be ramped up and then down again (for 30 seconds total) to simulate the feeling of active stimulation. |
Sham Comparator: Sham tDCS and sham Mirrory Therapy
Subjects will receive 20 minutes of sham tDCS, while receiving 15 minutes of sham Mirror Therapy.
|
Device: transcranial Direct Current Stimulation (tDCS): sham (Soterix ©)
Subjects will undergo tDCS stimulation. For both active and sham stimulation, we will use electrodes of 35cm^2, at an intensity of 2mA on the primary motor cortex contralateral to the amputated leg. The subject will undergo stimulation for 20 minutes. This is the same parameters as the active one, except the current will be ramped up and then down again (for 30 seconds total) to simulate the feeling of active stimulation. Behavioral: Mirror Therapy: Sham Subjects will be asked to perform movements (15 minutes daily) using the unaffected limb while watching its mirrored reflection superimposed over the affected limb, only the mirror will be covered. During Mirror Therapy, subjects will be asked to consciously relate the movement observed in the mirror to their phantom limb and to keep their attention focused on the task. Instructions will be explained verbally, demonstrated by a therapist, and performed by the subject in front of the therapist. We will use the same all of these techniques as active Mirror Therapy only the mirror will be covered during all activities. |
- Changes in the Visual Analog Scale for Phantom Limb Pain [ Time Frame: 4 weeks ]The primary endpoint will be the severity of pain measured by changes in PLP from baseline to 4 weeks (value at 4 weeks minus value at baseline), as indexed by a Visual Analog Scale (VAS). The VAS pain scale is a simple 10- point scale (0 = ''no pain'', 10 = ''pain as bad as you can imagine''). Since we are using a difference, smaller values (negative) represent a better outcome.
- Changes in the Visual Analog Scale for Stump Pain [ Time Frame: 4 weeks ]The endpoint will be the severity of pain measured by changes in Stump Pain from baseline to 4 weeks (value at 4 weeks minus value at baseline), as indexed by a Visual Analog Scale (VAS). The VAS Phantom Limb Stump Pain scale is a simple 10- point scale (0 = ''no Phantom Limb Stump Pain'', 10 = ''Phantom Limb Stump Pain as bad as you can imagine''). Since we are using a difference, smaller values (negative) represent a better outcome.
- Changes in the Visual Analog Scale for Phantom Limb Sensation [ Time Frame: 4 weeks ]The endpoint will be the severity of pain measured by changes in Phantom Limb Sensation from baseline to 4 weeks (value at 4 weeks minus value at baseline), as indexed by a Visual Analog Scale (VAS). The VAS Phantom Limb Sensation scale is a simple 10- point scale (0 = ''no Phantom Limb Sensation'', 10 = ''Phantom Limb Sensation as much as you can imagine''). Since we are using a difference, smaller values (negative) represent a better outcome.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Able to provide informed consent to participate in the study.
- Subject is older than 18 years.
- Unilateral lower limb amputation.
- Traumatic amputation greater than 1 year ago.
- Chronic PLP for at least 3 months previous to enrollment in the study, experienced regularly for at least once a week.
- Average pain of at least 4 on a numeric rating scale in the previous week (NRS; ranging from 0 to 10).
- If the subject is taking any medications, dosages must be stable for at least 2 weeks prior to the enrollment of the study.
Exclusion Criteria:
- Pregnancy or trying to become pregnant in the next 2 months.
- History of alcohol or drug abuse within the past 6 months as self-reported.
-
Presence of the following contraindication to transcranial direct current stimulation and transcranial magnetic stimulation
- Ferromagnetic metal in the head (e.g., plates or pins, bullets, shrapnel)
- Implanted neck or head electronic medical devices (e.g., cochlear implants, vagus nerve stimulator)
- History of chronic pain previous to the amputation.
- Head injury resulting in loss of consciousness for at least 30 min or pos-traumatic amnesia for greater than 24 hours, as self-reported
- Unstable medical conditions (e.g. uncontrolled diabetes, uncompensated cardiac issues, heart failure or chronic obstructive pulmonary disease).
- Uncontrolled Epilepsy or prior seizures within the last 1 year.
- Suffering from severe depression (as defined by a score of >30 in the Beck Depression Inventory).*
- History of unexplained fainting spells or loss of consciousness as self-reported during the last 2 years.
- History of neurosurgery, as self-reported.
- Mirror Therapy in the previous 3 months

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02487966
United States, Massachusetts | |
Spaulding Rehabilitation Network Research Institute | |
Charlestown, Massachusetts, United States, 02129 | |
Brazil | |
IMREA HCFMUSP - Rede Lucy Montoro | |
São Paulo, Brazil, 04116-030 |
Principal Investigator: | Felipe Fregni, MD, PhD, MPH | Spaulding Rehabilitation Hospital |
Documents provided by Felipe Fregni, MD, PhD, MPH, Spaulding Rehabilitation Hospital:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | Felipe Fregni, MD, PhD, MPH, Principal Investigator, Spaulding Rehabilitation Hospital |
ClinicalTrials.gov Identifier: | NCT02487966 |
Other Study ID Numbers: |
2015P001065 |
First Posted: | July 2, 2015 Key Record Dates |
Results First Posted: | June 21, 2021 |
Last Update Posted: | August 15, 2022 |
Last Verified: | August 2022 |
Studies a U.S. FDA-regulated Device Product: | No |
tDCS Mirror Therapy Phantom Limb Pain Traumatic amputation |
Phantom Limb Amputation, Traumatic Perceptual Disorders Neurobehavioral Manifestations Neurologic Manifestations Nervous System Diseases |
Pain, Postoperative Postoperative Complications Pathologic Processes Pain Wounds and Injuries |